熱門資訊> 正文
细胞内疗法任命Sanjeev Narula为首席财务官
2024-08-07 19:59
- Intra-Cellular Therapies (NASDAQ:ITCI) said it has appointed Sanjeev Narula as CFO, and executive vice president.
- Narula will join the company on August 12.
- Current finance chief, Lawrence Hineline will retire on the same date.
More on Intra-Cellular Therapies
- Intra-Cellular Brightens MDD Outlook With Caplyta Success
- Intra-Cellular gains after late-stage win for mood disorder therapy
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。